Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Blinatumomab
Related studies linked through entity extraction aliases.
Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Blinatumomab for Treatment of Refractory Myasthenia Gravis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
The Use of Blinatumomab in Patients With NGS-MRD Relapsed B-ALL After Autologous/Allogeneic Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Blinatumomab Maintenance After Allo-HSCT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
- Status
- RECRUITING
- Phase
- PHASE4
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2